A Review on: Indian Pharma Regulatory System and List of New Drugs Approved By Central Drugs Standard Control Organization in the Year 2021 Till Date

Authors

  • Poonam Yadav Department of Pharmaceutical Sciences, Maharishi Dayan and University, Rohtak, Haryana, India
  • Kavita Bahmani Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India
  • Neelam Pawar Department of Pharmaceutical Sciences, Chaudhary Bansilal University, Bhiwani, Haryana, India
  • Ankita Sharma Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India

Keywords:

Central Drugs Standard Control Organization approved drugs, Common technical document filing, Drug approval process, Regulatory bodies

Abstract

Regulatory authorities and organizations play a crucial part in responding to the requirements of regulatory proceedings related to drug development in a region. Each country has its owned regulatory body, that is, liable for implementing laws and regulations, as well as offering guidance to control the evolution, grant/licensing, and registration of drugs. The Indian pharmaceutical industry is one of the most organized industries in the country. Knowing the scenario of regulatory bodies plays a vital importance because of the fast and continuous change and because of the pressure placed on regulators to maintain a steady availability of quality medicines at an economical price to the Indian masses. Current article focuses on the drug approval process and regulatory requirements according to the Central Drugs Standard Control Organization.

Downloads

Download data is not yet available.

Downloads

Published

2021-12-27

How to Cite

Poonam Yadav, Kavita Bahmani, Neelam Pawar, & Ankita Sharma. (2021). A Review on: Indian Pharma Regulatory System and List of New Drugs Approved By Central Drugs Standard Control Organization in the Year 2021 Till Date. Asian Pacific Journal of Health Sciences, 8(4), 222–227. Retrieved from https://apjhs.com/index.php/apjhs/article/view/1877

Issue

Vol. 8 No. 4 (2021): Vol 8 | Issue 4 | October - December 2021

Section

Articles

License

Copyright (c) 2021 Poonam Yadav, Kavita Bahmani, Neelam Pawar, Ankita Sharma

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.